These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Dandona P; Aljada A; Chaudhuri A; Mohanty P; Garg R Circulation; 2005 Mar; 111(11):1448-54. PubMed ID: 15781756 [No Abstract] [Full Text] [Related]
5. [Risk factors and etiology of retinal vein occlusion]. Zhioua R; Sebaï L; Kriaa L; el Euch M; Mabrouk S; Ouertani A Tunis Med; 1995 Feb; 73(2):133-6. PubMed ID: 9506155 [No Abstract] [Full Text] [Related]
6. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. Lewis GF; Steiner G Diabetes Metab Rev; 1996 Apr; 12(1):37-56. PubMed ID: 8861500 [No Abstract] [Full Text] [Related]
7. Metabolic syndrome' in a middle-aged Finnish population. Vanhala MJ; Kumpusalo EA; Pitkäjärvi TK; Takala JK J Cardiovasc Risk; 1997 Aug; 4(4):291-5. PubMed ID: 9477208 [TBL] [Abstract][Full Text] [Related]
8. [Relationship between parameters of hemostasis and manifestations of the metabolic syndrome in men with mild and moderate hypertension]. Ratnikova LA; Metel'skaia VA; Mamedov MN; Olfer'ev AM; Perova NV Ter Arkh; 2000; 72(9):13-6. PubMed ID: 11076408 [TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome: what's in a name? Wubben DP; Adams AK WMJ; 2006 Jul; 105(5):17-20. PubMed ID: 16933408 [TBL] [Abstract][Full Text] [Related]
10. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice. Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870 [TBL] [Abstract][Full Text] [Related]
11. [Hypertriglyceridemia and arteriosclerosis]. Hata Y Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1795-805. PubMed ID: 1479221 [No Abstract] [Full Text] [Related]
12. The clinical implications of insulin resistance. Peters AL Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420 [TBL] [Abstract][Full Text] [Related]
13. A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Malloy MJ; Kane JP Adv Intern Med; 2001; 47():111-36. PubMed ID: 11795072 [TBL] [Abstract][Full Text] [Related]
18. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults. Appel SJ; Harrell JS; Davenport ML J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162 [TBL] [Abstract][Full Text] [Related]
19. [Metabolic and hormonal links in obese individuals with and without symptoms of syndrome X]. Nedĕlníková K; Svacina S; Matoulek M; Sonka J Sb Lek; 2000; 101(1):67-9. PubMed ID: 10953633 [TBL] [Abstract][Full Text] [Related]
20. [Insulin resistance and metabolic syndrome in first-degree relatives of patients with NIDDM]. Camps I; Biarnés J; Fernández-Real JM; Insa R; Soler J; Fernández Castañer M Med Clin (Barc); 1999 Mar; 112(8):281-4. PubMed ID: 10207842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]